Lupus genes at the interface of tolerance and autoimmunity

References

• Klippel JH. Systemic lupus erythematosus: demographics, prognosis, and outcome. J. Rheumatol. Suppl.48, 67–71 (1997).
   PubMedGoogle Scholar
• Hochberg MC. Systemic lupus erythematosus. Rheum. Dis. Clin. North Am.16, 617–639 (1990).
   PubMed Web of Science ®Google Scholar
• Kumar KR, Li L, Yan M et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science312, 1665–1669 (2006).
   PubMed Web of Science ®Google Scholar
• Wakeland EK, Wandstrat AE, Liu K, Morel L. Genetic dissection of systemic lupus erythematosus. Curr. Opin. Immunol.11, 701–707 (1999).
   PubMed Web of Science ®Google Scholar
• Yurasov S, Wardemann H, Hammersen J et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med.201, 703–711 (2005).
   PubMed Web of Science ®Google Scholar
• Singh NJ, Schwartz RH. Primer: mechanisms of immunologic tolerance. Nat. Clin. Pract. Rheumatol.2, 44–52 (2006).
   PubMedGoogle Scholar
• Goodnow CC, Sprent J, Fazekas de St GB, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature435, 590–597 (2005).
   PubMed Web of Science ®Google Scholar
• Gommerman JL, Carroll MC. Negative selection of B lymphocytes: a novel role for innate immunity. Immunol. Rev.173, 120–130 (2000).
   PubMedGoogle Scholar
• Cook HT, Botto M. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol.2, 330–337 (2006).
   PubMedGoogle Scholar
• Botto M. Links between complement deficiency and apoptosis. Arthritis Res.3, 207–210 (2001).
   PubMedGoogle Scholar
• Krishnan S, Chowdhury B, Tsokos GC. Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin. Immunol.18, 230–243 (2006).
   PubMed Web of Science ®Google Scholar
• Botto M, Dell’Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet.19, 56–59 (1998).
   PubMed Web of Science ®Google Scholar
• Trendelenburg M, Manderson AP, Fossati-Jimack L, Walport MJ, Botto M. Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice. Immunology113, 80–88 (2004).
   PubMedGoogle Scholar
• Cutler AJ, Cornall RJ, Ferry H, Manderson AP, Botto M, Walport MJ. Intact B cell tolerance in the absence of the first component of the classical complement pathway. Eur. J. Immunol.31, 2087–2093 (2001).
   PubMedGoogle Scholar
• Ferry H, Potter PK, Crockford TL et al. Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice. J. Immunol.178, 2916–2922 (2007).
   PubMedGoogle Scholar
• Chen Z, Koralov SB, Kelsoe G. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med.192, 1339–1352 (2000).
   PubMed Web of Science ®Google Scholar
• Ittiprasert W, Kantachuvesiri S, Pavasuthipaisit K et al. Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations. J. Autoimmun.25, 77–84 (2005).
   PubMedGoogle Scholar
• Prodeus AP, Goerg S, Shen LM et al. A critical role for complement in maintenance of self-tolerance. Immunity9, 721–731 (1998).
   PubMed Web of Science ®Google Scholar
• Christensen SR, Shlomchik MJ. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin. Immunol.19(1), 11–23 (2007).
   PubMed Web of Science ®Google Scholar
• Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science312, 1669–1672 (2006).
   PubMed Web of Science ®Google Scholar
• Subramanian S, Tus K, Li QZ et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl Acad. Sci. USA103, 9970–9975 (2006).
   PubMed Web of Science ®Google Scholar
• Berland R, Fernandez L, Kari E et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity25, 429–440 (2006).
   PubMed Web of Science ®Google Scholar
• Lau CM, Broughton C, Tabor AS et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med.202, 1171–1177 (2005).
   PubMed Web of Science ®Google Scholar
• Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity25, 417–428 (2006).
   PubMed Web of Science ®Google Scholar
• Hur JW, Shin HD, Park BL, Kim LH, Kim SY, Bae SC. Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens65, 266–270 (2005).
   PubMed Web of Science ®Google Scholar
• Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol.18, 676–682 (2006).
   PubMed Web of Science ®Google Scholar
• Takaoka A, Yanai H, Kondo S et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature434, 243–249 (2005).
   PubMed Web of Science ®Google Scholar
• Reddy MV, Velazquez-Cruz R, Baca V et al. Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum. Genet. (2007) (Epub ahead of print).
   Google Scholar
• Graham RR, Kozyrev SV, Baechler EC et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet.38, 550–555 (2006).
   PubMed Web of Science ®Google Scholar
• Demirci FY, Manzi S, Ramsey-Goldman R et al. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann. Hum. Genet.71, 308–311 (2007).
   PubMed Web of Science ®Google Scholar
• Gessner JE, Heiken H, Tamm A, Schmidt RE. The IgG Fc receptor family. Ann. Hematol.76, 231–248 (1998).
   PubMed Web of Science ®Google Scholar
• Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(γ)RIIB-deficient mice results from strain-specific epistasis. Immunity13, 277–285 (2000).
   PubMed Web of Science ®Google Scholar
• Jiang Y, Hirose S, Abe M et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics51, 429–435 (2000).
   PubMed Web of Science ®Google Scholar
• Wu J, Edberg JC, Redecha PB et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest.100, 1059–1070 (1997).
   PubMed Web of Science ®Google Scholar
• Siriboonrit U, Tsuchiya N, Sirikong M et al. Association of Fcγ receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens61, 374–383 (2003).
   PubMed Web of Science ®Google Scholar
• Mackay M, Stanevsky A, Wang T et al. Selective dysregulation of the FcγIIB receptor on memory B cells in SLE. J. Exp. Med.203, 2157–2164 (2006).
   PubMed Web of Science ®Google Scholar
• Fukuyama H, Nimmerjahn F, Ravetch JV. The inhibitory Fcγ receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat. Immunol.6, 99–106 (2005).
   PubMed Web of Science ®Google Scholar
• Ashman RF, Peckham D, Stunz LL. Fc receptor off-signal in the B cell involves apoptosis. J. Immunol.157, 5–11 (1996).
   PubMed Web of Science ®Google Scholar
• Wandstrat AE, Nguyen C, Limaye N et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity21, 769–780 (2004).
   PubMed Web of Science ®Google Scholar
• MacKay F, Woodcock SA, Lawton P et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med.190, 1697–1710 (1999).
   PubMed Web of Science ®Google Scholar
• Kalled SL. The role of BAFF in immune function and implications for autoimmunity. Immunol. Rev.204, 43–54 (2005).
   PubMed Web of Science ®Google Scholar
• Ng LG, Mackay CR, MacKay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol.42, 763–772 (2005).
   PubMedGoogle Scholar
• Tan SM, Xu D, Roschke V et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum.48, 982–992 (2003).
   PubMed Web of Science ®Google Scholar
• Brink R. Regulation of B cell self-tolerance by BAFF. Semin. Immunol.18, 276–283 (2006).
   PubMed Web of Science ®Google Scholar
• Craxton A, Draves KE, Gruppi A, Clark EA. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J. Exp. Med.202, 1363–1374 (2005).
   PubMed Web of Science ®Google Scholar
• Oliver PM, Vass T, Kappler J, Marrack P. Loss of the proapoptotic protein, Bim, breaks B cell anergy. J. Exp. Med.203, 731–741 (2006).
   PubMedGoogle Scholar
• Ng LG, Sutherland AP, Newton R et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol.173, 807–817 (2004).
   PubMed Web of Science ®Google Scholar
• Cohen PL, Eisenberg RA. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today13, 427–428 (1992).
   PubMedGoogle Scholar
• Del Rey M, Ruiz-Contreras J, Bosque A et al. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood108, 1306–1312 (2006).
   PubMedGoogle Scholar
• Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest.98, 1107–1113 (1996).
   PubMed Web of Science ®Google Scholar
• Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death. Differ.10, 124–133 (2003).
   PubMed Web of Science ®Google Scholar
• Roark JH, Kuntz CL, Nguyen KA, Caton AJ, Erikson J. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med.181, 1157–1167 (1995).
   PubMed Web of Science ®Google Scholar
• Brard F, Shannon M, Prak EL, Litwin S, Weigert M. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J. Exp. Med.190, 691–704 (1999).
   PubMedGoogle Scholar
• Li Y, Li H, Ni D, Weigert M. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J. Exp. Med.196, 1543–1552 (2002).
   PubMedGoogle Scholar
• Rathmell JC, Goodnow CC. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol.153, 2831–2842 (1994).
   PubMed Web of Science ®Google Scholar
• Eguchi K. Apoptosis in autoimmune diseases. Intern. Med.40, 275–284 (2001).
   PubMed Web of Science ®Google Scholar
• Strasser A, Whittingham S, Vaux DL et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl Acad. Sci. USA88, 8661–8665 (1991).
   PubMed Web of Science ®Google Scholar
• Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis. Clin. Dev. Immunol.13, 283–287 (2006).
   PubMedGoogle Scholar
• Miret C, Font J, Molina R et al. Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity. Anticancer Res.19, 3073–3076 (1999).
   PubMedGoogle Scholar
• Miret C, Font J, Molina R et al. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, α-TNF) with the activity of systemic lupus erythematosus. Anticancer Res.21, 3053–3059 (2001).
   PubMedGoogle Scholar
• Lang J, Arnold B, Hammerling G et al. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med.186, 1513–1522 (1997).
   PubMed Web of Science ®Google Scholar
• Fang W, Weintraub BC, Dunlap B et al. Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity9, 35–45 (1998).
   PubMed Web of Science ®Google Scholar
• Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell67, 889–899 (1991).
   PubMed Web of Science ®Google Scholar
• Willis SN, Adams JM. Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol.17, 617–625 (2005).
   PubMed Web of Science ®Google Scholar
• Bouillet P, Metcalf D, Huang DC et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science286, 1735–1738 (1999).
   PubMed Web of Science ®Google Scholar
• Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med.198, 1119–1126 (2003).
   PubMed Web of Science ®Google Scholar
• Bouillet P, Purton JF, Godfrey DI et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature415, 922–926 (2002).
   PubMed Web of Science ®Google Scholar
• Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Semin. Immunol.18, 214–223 (2006).
   PubMed Web of Science ®Google Scholar
• Kyogoku C, Langefeld CD, Ortmann WA et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet.75, 504–507 (2004).
   PubMed Web of Science ®Google Scholar
• Baca V, Velazquez-Cruz R, Salas-Martinez G, Espinosa-Rosales F, Saldana-Alvarez Y, Orozco L. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immun.7, 693–695 (2006).
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science303, 685–689 (2004).
   PubMed Web of Science ®Google Scholar
• Okazaki T, Wang J. PD-1/PD-L pathway and autoimmunity. Autoimmunity38, 353–357 (2005).
   PubMed Web of Science ®Google Scholar
• Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity11, 141–151 (1999).
   PubMed Web of Science ®Google Scholar
• Prokunina L, Castillejo-Lopez C, Oberg F et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet.32, 666–669 (2002).
   PubMed Web of Science ®Google Scholar
• Thorburn CM, Prokunina-Olsson L, Sterba KA et al. Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun. (2007).
   PubMedGoogle Scholar
• Slingsby JH, Norsworthy P, Pearce G et al. Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families. Arthritis Rheum.39, 663–670 (1996).
   PubMed Web of Science ®Google Scholar
• Yasutomo K, Horiuchi T, Kagami S et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet.28, 313–314 (2001).
   PubMed Web of Science ®Google Scholar
• Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity38, 55–63 (2005).
   PubMed Web of Science ®Google Scholar
• Russell AI, Cunninghame Graham DS, Shepherd C et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum. Mol. Genet.13, 137–147 (2004).
   PubMed Web of Science ®Google Scholar
• Graham RR, Ortmann WA, Langefeld CD et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet.71, 543–553 (2002).
   PubMed Web of Science ®Google Scholar
• Lee YH, Harley JB, Nath SK. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum. Genet.116, 361–367 (2005).
   PubMed Web of Science ®Google Scholar
• Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum. Genet.111, 452–455 (2002).
   PubMed Web of Science ®Google Scholar